Cat. No. |
Product Name |
Information |
PC-63299 |
Bedaquiline fumarate
|
Bedaquiline fumarate (R403323, TMC207 fumarate, R207910 fumarate) is a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections.. |
PC-43057 |
TBA-354
Antitubercular agent
|
TBA-354 is a novel antitubercular agent that shows MIC of 6 uM against M. tuberculosis H37Rv. |
PC-62613 |
Nacubactam
|
Nacubactam (OP 0595, RG 6080, RO 7079901) is a diazabicyclooctane that inhibits class A and C β-lactamases with IC50 of <1 uM, also acts as a PBP2-active antibacterial. |
PC-62609 |
DS86760016
LeuRS inhibitor
|
DS86760016 is a novel selective bacterial leucyl-tRNA synthetase (LeuRS) inhibitor with IC50 of 0.38 uM (Escherichia coli, LeuRS). |
PC-62571 |
BAL30072
Antibiotic
|
BAL30072 is a monocyclic beta-lactam antibiotic that shows potent activity against MDR Pseudomonas aeruginosa and Acinetobacter sp. Isolates with MIC90 of 8 and 4 ug/ml. |
PC-62564 |
ABMA
|
ABMA is a novel broad-spectrum inhibitor of intracellular toxins and pathogens, efficiently protects cells against various toxins and pathogens including viruses, intracellular bacteria and parasite. |
PC-62251 |
MAC173979
PABA biosynthesis inhibitor
|
MAC173979 is a novel time-dependent inhibitor of p-aminobenzoic acid biosynthesis with IC50 of 30 uM, represents the first PABA biosynthesis inhibitor with activity against Gram-negative bacteria.. |
PC-62250 |
MAC168425
Antibiotic
|
MAC168425 is a novel antibacterial inhibitor that interferes with glycine metabolism in E coli.. |
PC-61938 |
GSK-2140944
Bacterial Topo II inhibitor
|
GSK-2140944 (Gepotidacin) is a novel potent, selective bacterial type II topoisomerase inhibitor in development for the treatment of conventional and biothreat pathogens, including Gram-positive pathogens and MRSA. |
PC-61783 |
Inh2-B1
STK1 inhibitor
|
Inh2-B1 (STK1 inhibitor B1) is a novel specific S aureus Ser/Thr protein kinase (STK1) inhibitor with IC50 of 49 uM, directly binds to ATP-binding catalytic domain. |
PC-61756 |
NITD-304
MmpL3 inhibitor
|
NITD-304 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 15 nM against M tuberculosis H37Rv. |
PC-61751 |
AU-1235
MmpL3 inhibitor
|
AU-1235 is a novel, specific mycobacterial membrane protein large 3 (MmpL3) inhibitor with MIC of 0.1 ug/mL (0.3 uM) against Mtb H37Rv.. |